About Seutic
Seutic is a Healthcare company based in Bidar (India). It operates as a specialty company focused on pharmaceutical development and API manufacturing. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 58 employees. Its Indian entity Seutic Pharma Private Limited reported revenue of ₹66.83 Cr. Seutic offers products and services including Active Ingredients, Intermediates, and Research Development. Its focus areas include Pharmaceuticals, API Manufacturing, Active Ingredients and Intermediates Production. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Seutic Pharma Is A Specialty Pharmaceutical Company That Develops, Manufactures, And Markets Active Pharmaceutical Ingredients And Intermediates. Based In Hyderabad, India, It Operates Advanced Rd And Manufacturing Facilities Adhering To Ich And Cgmp Guidelines. The Company Targets Therapeutic Areas Like Anti-malarial And Cardiovascular, Investing In Innovation For Domestic And International Markets. It Emphasizes Quality Infrastructure And Environmental Safety In Operations.
- Headquarters Bidar, India
- Employees 58
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website seutic.com
- Legal Name Seutic Pharma Pvt Ltd
- Date of Incorporation 23 Jul, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹66.83 Cr
FY 2025 · -24% YoY
- Net Loss-₹54.3 Lakh
FY 2025 · -1% margin
- EBITDA₹5.66 Cr
FY 2025 · 8% margin
- Employee Count58
Associated legal entities of Seutic
Seutic is associated with 2 registered companies on The Company Check; the primary company is Seutic Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Seutic Pharma Private Limited CIN U24297TG2014PTC095025 | Active | 23 Jul 2014 | Hyderabad, Telangana | ₹66.8 Cr | 58 | 6 | View details |
| Seutic Labs Private Limited CIN U24100TG2016PTC102893 | Active | 27 Jan 2016 | Hyderabad, Telangana | ₹74.8 Cr | 74 | 6 | View details |
Products & Services of Seutic
Seutic offers a comprehensive portfolio of products and services, including Active Ingredients, Intermediates, and Research Development.
Manufacture of pharmaceutical active ingredients for global markets
Production of intermediates used in drug development
Services for pharmaceutical research and innovation processes
Board of directors of Seutic Pharma Private Limited (Seutic)
Seutic Pharma Private Limited is the primary company behind Seutic. The boards of the 2 registered companies of Seutic currently have 6 directors; the longest-serving is Venkata Siva Vara Prasad Valivarthi, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Siva Vara Prasad Valivarthi DIN 02182277 | Director | 23 Jul 2014 | 12 yrs 2 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
| Padma Valivarthi DIN 06928031 | Director | 23 Jul 2014 | 12 yrs 2 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
| Sudhakar Kalle DIN 10936865 | Additional Director | 22 May 2025 | 1 yr 5 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
| Punukollu Kodanda Rambabu DIN 00069047 | Additional Director | 27 Jun 2025 | 1 yr 3 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
| Jayaram Gunturu DIN 06475335 | Additional Director | 27 Jun 2025 | 1 yr 3 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
| Prithvi Prasad Motaparti DIN 11177262 | Additional Director | 11 Jul 2025 | 1 yr 3 mo | Seutic Pharma Private Limited, Seutic Labs Private Limited |
Financials of Seutic
Figures of Seutic Pharma Private Limited, the primary company behind Seutic, for FY 2025. Revenue was ₹66.83 Cr (-24% year on year). Net loss was -₹54.3 Lakh (-1% margin). EBITDA was ₹5.66 Cr (8% margin). Revenue has grown at a compounded annual rate of +9% over three years and +9% over five years.
- ₹66.83 CrRevenue · FY 2025 · -24% YoY
- -₹54.3 LakhNet loss · -1% margin
- ₹5.66 CrEBITDA · 8% margin
- ₹6.00 CrPaid-up capital
- 58Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Seutic Pharma Private Limited are on its company page.
Detailed financial statements for Seutic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Seutic
Seutic has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Seutic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Seutic (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Seutic
Seutic is headquartered in Bidar, India. It is registered at Bidar, Karnataka, India.
Seutic has 58 employees.
The primary company behind Seutic, Seutic Pharma Private Limited, reported revenue of ₹66.83 Cr for FY 2025, down 24% year on year.
Seutic Pharma Is A Specialty Pharmaceutical Company That Develops, Manufactures, And Markets Active Pharmaceutical Ingredients And Intermediates. Based In Hyderabad, India, It Operates Advanced Rd And Manufacturing Facilities Adhering To Ich And Cgmp Guidelines. The Company Targets Therapeutic Areas Like Anti-malarial And Cardiovascular, Investing In Innovation For Domestic And International Markets. It Emphasizes Quality Infrastructure And Environmental Safety In Operations.
Seutic's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Seutic offers Active Ingredients, Intermediates, and Research Development.
Seutic is associated with 2 legal entities: Seutic Pharma Private Limited, Seutic Labs Private Limited.
The legal entities of Seutic currently have 6 directors, including Venkata Siva Vara Prasad Valivarthi, Padma Valivarthi, Punukollu Kodanda Rambabu and others.